Effects of Omega-3 Fatty Acid Supplementation in Acne Patients

Stopped early · Phase 3 · Has a placebo group

Conditions studied: Acne

In brief

60 patients receiving isotretinoin will be recruited from the UCLA acne specialty clinic. Subjects will be randomized in a 1:1 ratio to receive placebo or omega-3 1200mg twice a day for 24 weeks.

Key facts

Study ID

NCT01764308

Run by

University of California, Los Angeles

People needed

31

Starts

2013-01-01

Expected to finish

2019-03-31

Last updated by the study team

2019-04-17

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Male or female above 18 years of age.
• Moderate to severe disease at the baseline of the study identified by their dermatologist.
• Will start treatment with systemic therapy for acne in the form of either isotretinoin or oral antibiotics.
• Patients able and willing to comply with the procedures in the study protocol.

You may not qualify if…

• Patients with history of taking omega-3 supplements for high triglyceride levels.
• Patients taking medications for dyslipidemia, blood thinners, or high blood pressure medication.
• Patients with a history of adverse reaction to omega-3 fatty acid supplementation.
• Unwilling to give inform consent

Where it is running

• University of Califonia, Los Angeles Division of Dermatology — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.